This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions. From clinical trials like PIONEER-AF and VOYAGER PAD to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.
Intracranial Activity of ROS1 TKIs
Current Guidelines and Real-World Evidence for ROS1 Testing in NSCLC
First-Line Targeted Therapies for ROS1 Fusion-Positive Lung Cancers
Clinical Challenges With Triple-Class or Penta-Refractory MM
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
Integrating Bispecific Antibodies Into Clinical Practice
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Efficacy Data for Bispecific Antibodies in RRMM
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Considerations for Dosing Bispecific Antibodies
5 Things You Need to Know About Epilepsy & Depression
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ovarian Cancer: PARP Inhibitor-Related Adverse Events and Team-Based Care
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ovarian Cancer: Cytogenetic Testing and PARP Inhibition for Maintenance Treatment
Practical Management of Variceal Bleeding and Hepatorenal Syndrome
Emerging Data in the Management of Acute Ischemic Stroke/TIA
Preventing Ischemic Stroke in Today’s World
While Antiplatelets Are Good…They Aren’t for Everyone
Create your
podcast in
minutes
It is Free
RenaissanceOnlineRadio.com
Men in Lead Aprons
Denver Underground
NASACast Video
Mysteries Abound